与患帕金森病的风险相关的可修改风险因素:批判性审查
Vitor Tumas1, Marcelo Jhonatan Aureliano2, Carlos Roberto de Melo Rieder3
1Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto SP, Brazil.
Arquivos de neuro-psiquiatria
|March 19, 2025
概括
环境因素显著影响帕金森氏症.
科学领域:
- 环境健康 环境健康
- 神经科学是一个神经科学.
- 流行病学 流行病学
背景情况:
- 帕金森病 (PD) 的病因涉及复杂的基因环境相互作用.
- 遗传因素是众所周知的,但环境影响需要进一步探索.
- 确定环境风险和保护因素对于PD预防至关重要.
研究的目的:
- 审查具体证据,将环境因素与帕金森病风险联系起来.
- 整合关于保护性和与风险相关的环境暴露的发现.
- 突出需要进一步研究PD环境病因学的领域.
主要方法:
- 现有科学文献的叙述性审查.
- 研究环境/生活方式因素和PD风险的综合研究.
- 对关联的证据分析,包括保护性,风险和有争议的因素.
主要成果:
- 保护因素包括体力活动,健康饮食,戒烟和摄入咖啡因.
- 确定了风险因素:头部创伤,乳制品消费,农药暴露,糖尿病.
- 有争议的因素:酒精,农村生活,农业,井水,NSAID使用.
结论:
- 环境因素是帕金森病发展的重要风险标志物.
- 了解这些因素可以为PD的风险修改策略提供信息.
- 需要进一步的研究来澄清有争议的关联,并探索新的环境联系.
相关概念视频
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...


